Filter By Industry
Filter By Tag


Huateng Pharma Press releases

1 - 10 of 39 Press Releases

Aug 18, 2023
Minoxidil was first introduced by Upjohn Company of the United States, and was first used as an oral drug for the treatment of refractory hypertension in the 1970s.

Jul 27, 2023
Diabetes is a serious chronic disease characterized by elevated blood sugar concentrations associated with the effects of abnormal beta cell biology on insulin action.

Jun 28, 2023
Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and also causes the greatest number of cancer-related deaths among women.

Apr 20, 2023
SGLT-2 inhibitor is a new type of oral hypoglycemic drug that has received great attention in recent years.

Mar 21, 2023
In recent years, targeted protein degradation (TPD) technology has developed rapidly, especially proteolysis targeting chimera (PROTAC), which is the most representative technology of TPD strategy.

Feb 20, 2023
Tetrahydrocurcumin (THC) has obvious antioxidant effect and has been used as a natural functional whitening raw material for cosmetics research and development.

Jan 28, 2023
Fluralaner is a systemic insecticide and acaricide that can be administered orally or topically. Bravecto is the trade name. The U.S.

Nov 28, 2022
Carfilzomib, a proteasome inhibitor, is indicated for the treatment of patients with multiple myeloma.

Oct 25, 2022
According to the latest IDF Diabetes map, the global prevalence of diabetes reached 10.5% in 2021, with 537 million adults living with diabetes. China has become a disaster zone for diabetes, with the largest number of adults with diabetes in the world.

Sep 26, 2022
Although the treatment of type 2 diabetes (T2DM) has made impressive progress in the past few decades, researchers are constantly searching for new treatments.

Page: 1 2 3 4 Next
Huateng Pharma RSS Feed